R

Radiopharm Theranostics Ltd
ASX:RAD

Watchlist Manager
Radiopharm Theranostics Ltd
ASX:RAD
Watchlist
Price: 0.019 AUD Market Closed
Market Cap: 52.8m AUD

Gross Margin
Radiopharm Theranostics Ltd

1.1%
Current
-3%
Average
63.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
1.1%
=
Gross Profit
39.3k
/
Revenue
3.6m

Gross Margin Across Competitors

No Stocks Found

Radiopharm Theranostics Ltd
Glance View

Market Cap
52.8m AUD
Industry
Biotechnology

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-11-25. The firm is a developer of platform of radiopharmaceutical products for both diagnostic and therapeutic uses. The company has a pipeline of four licensed platform technologies, namely Nano- monoclonal antibodies (mAbs) technology, Pivalate, AVb6 Integrin and PSA-mAb. Nano-mAbs technology platform provides Nano-mAbs, which are made using genetically engineered camelid derived single domain antibodies (sdAb), that are labelled with radioisotopes to diagnose and treat specific cancers expressing HER-2, TROP-2, PD-L1 and PTK7 receptors. Pivalate is an F-FPIA radiotracer, and its technology is based on a short chain carbohydrate. Its clinical program includes five Phase I clinical trials, five Phase II clinical trials, and two Phase I clinical trials targeting a various cancer, including breast, lung, kidney, head and neck, pancreatic and brain. Its pipeline consists of RAD101, RAD102, RAD104, RAD105, RAD106, and RAD201 among others.

RAD Intrinsic Value
Not Available
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
1.1%
=
Gross Profit
39.3k
/
Revenue
3.6m
What is the Gross Margin of Radiopharm Theranostics Ltd?

Based on Radiopharm Theranostics Ltd's most recent financial statements, the company has Gross Margin of 1.1%.

Back to Top